Are women with osteoporosis treated with denosumab at risk of severe COVID-19?
作者信息
Formenti Anna Maria, Pedone Erika, di Filippo Luigi, Ulivieri Fabio Massimo, Giustina Andrea
机构信息
Institute of Endocrine and Metabolic Sciences, Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Milan, Italy.
出版信息
Endocrine. 2020 Nov;70(2):203-205. doi: 10.1007/s12020-020-02500-4. Epub 2020 Sep 20.
Abstract
摘要
相似文献
1
Are women with osteoporosis treated with denosumab at risk of severe COVID-19?接受地诺单抗治疗的骨质疏松症女性是否有患重症 COVID-19 的风险？
Endocrine. 2020 Nov;70(2):203-205. doi: 10.1007/s12020-020-02500-4. Epub 2020 Sep 20.
2
Osteoporosis in the age of COVID-19.COVID-19 时代的骨质疏松症。
Osteoporos Int. 2020 Jul;31(7):1189-1191. doi: 10.1007/s00198-020-05413-0. Epub 2020 Apr 28.
3
Corticosteroid-Induced Osteonecrosis in COVID-19: A Call For Caution.新型冠状病毒肺炎中皮质类固醇诱导的骨坏死：需谨慎对待
J Bone Miner Res. 2020 Sep;35(9):1828-1829. doi: 10.1002/jbmr.4136. Epub 2020 Aug 12.
4
Scientific Editing in the COVID-19 Era-Personal Vignettes from the JBMR Editors.
J Bone Miner Res. 2020 Jun;35(6):1005-1008. doi: 10.1002/jbmr.4050. Epub 2020 May 27.
5
COVID-19, Medical Education, and Bone Health: Insights From Project ECHO.2019冠状病毒病、医学教育与骨骼健康：来自ECHO项目的见解
J Clin Densitom. 2020 Jul-Sep;23(3):338-339. doi: 10.1016/j.jocd.2020.04.003. Epub 2020 May 8.
6
Bronchoalveolar lavage findings in severe COVID-19 pneumonia.重症新型冠状病毒肺炎的支气管肺泡灌洗结果
Intern Emerg Med. 2020 Oct;15(7):1333-1334. doi: 10.1007/s11739-020-02356-6. Epub 2020 May 15.
7
What can we learn about corticosteroid therapy as a treatment for COVID-19?关于皮质类固醇疗法作为治疗新冠肺炎的方法，我们能了解到什么？
Osteoporos Int. 2020 Aug;31(8):1595. doi: 10.1007/s00198-020-05487-w. Epub 2020 Jun 9.
8
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia.2019冠状病毒病（COVID-19）肺炎母亲所生新生儿中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的垂直传播
Obstet Gynecol. 2020 Sep;136(3):632-633. doi: 10.1097/AOG.0000000000004073.
9
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
10
Does active smoking worsen Covid-19?主动吸烟会使新冠肺炎恶化吗？
Eur J Intern Med. 2020 Jul;77:129-131. doi: 10.1016/j.ejim.2020.05.038. Epub 2020 May 28.
引用本文的文献
1
Calcium, Phosphorus and Magnesium Abnormalities Associated with COVID-19 Infection, and Beyond.与新型冠状病毒肺炎感染及其他情况相关的钙、磷和镁异常
Biomedicines. 2023 Aug 23;11(9):2362. doi: 10.3390/biomedicines11092362.
2
[Pituitary and COVID-19: review].[垂体与新型冠状病毒肺炎：综述]
Probl Endokrinol (Mosk). 2022 Jul 20;68(5):14-23. doi: 10.14341/probl13108.
3
The osteo-metabolic phenotype of COVID-19: an update.新型冠状病毒肺炎的骨代谢表型：更新。
Endocrine. 2022 Nov;78(2):247-254. doi: 10.1007/s12020-022-03135-3. Epub 2022 Jul 20.
4
Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic.在 COVID-19 大流行期间，抗骨质疏松药物的配给发生了变化。
Bone. 2022 Sep;162:116477. doi: 10.1016/j.bone.2022.116477. Epub 2022 Jun 29.
5
Effect of miR-144-3p-Targeted Regulation of PTEN on Proliferation, Apoptosis, and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells under Stretch.拉伸状态下miR-144-3p靶向调控PTEN对骨髓间充质干细胞增殖、凋亡和成骨分化的影响
Emerg Med Int. 2022 May 10;2022:5707504. doi: 10.1155/2022/5707504. eCollection 2022.
6
Remote management of osteoporosis in the first wave of the COVID-19 pandemic.远程管理 COVID-19 大流行第一波中的骨质疏松症。
Arch Osteoporos. 2022 Mar 2;17(1):37. doi: 10.1007/s11657-022-01069-x.
7
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic.回顾大流行两年后 COVID-19 的内分泌和代谢表现。
Rev Endocr Metab Disord. 2022 Apr;23(2):133-136. doi: 10.1007/s11154-022-09716-x. Epub 2022 Feb 19.
8
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study.抗骨质疏松药物与女性 COVID-19 相关结局无关：一项全国性队列研究。
Osteoporos Int. 2022 Jan;33(1):273-282. doi: 10.1007/s00198-021-06067-2. Epub 2021 Aug 17.
9
One year of the pandemic - how European endocrinologists responded to the crisis: a statement from the European Society of Endocrinology.疫情一年之际——欧洲内分泌学家如何应对危机：欧洲内分泌学会的声明。
Eur J Endocrinol. 2021 Jul 5;185(2):C1-C7. doi: 10.1530/EJE-21-0397.
10
Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance.COVID-19 期间骨质疏松症的诊断和管理：系统评价和实用指南。
Calcif Tissue Int. 2021 Oct;109(4):351-362. doi: 10.1007/s00223-021-00858-9. Epub 2021 May 18.
本文引用的文献
1
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19.内分泌学机制研究：维生素 D 与 COVID-19。
Eur J Endocrinol. 2020 Nov;183(5):R133-R147. doi: 10.1530/EJE-20-0665.
2
Endocrine and metabolic aspects of the COVID-19 pandemic.COVID-19 大流行的内分泌和代谢方面。
Rev Endocr Metab Disord. 2020 Dec;21(4):495-507. doi: 10.1007/s11154-020-09569-2.
3
Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19.低钙血症在新冠病毒肺炎患者中极为普遍，且预示着住院治疗情况。
Endocrine. 2020 Jun;68(3):475-478. doi: 10.1007/s12020-020-02383-5. Epub 2020 Jun 12.
4
Managing fragility fractures during the COVID-19 pandemic.管理 COVID-19 大流行期间的脆性骨折。
Nat Rev Endocrinol. 2020 Sep;16(9):467-468. doi: 10.1038/s41574-020-0379-z.
5
Osteoporosis Management in the Era of COVID-19.COVID-19 时代的骨质疏松症管理。
J Bone Miner Res. 2020 Jun;35(6):1009-1013. doi: 10.1002/jbmr.4049. Epub 2020 May 26.
6
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis.COVID-19 时期的内分泌学：钙代谢紊乱和骨质疏松症的管理。
Eur J Endocrinol. 2020 Aug;183(2):G57-G65. doi: 10.1530/EJE-20-0385.
7
Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection.一名接受甲状腺切除术后感染新冠病毒的女性出现严重低钙血症。
Endocrine. 2020 May;68(2):253-254. doi: 10.1007/s12020-020-02326-0. Epub 2020 Apr 28.
8
Osteoporosis in the age of COVID-19.COVID-19 时代的骨质疏松症。
Osteoporos Int. 2020 Jul;31(7):1189-1191. doi: 10.1007/s00198-020-05413-0. Epub 2020 Apr 28.
9
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.2019冠状病毒病与内分泌疾病。欧洲内分泌学会声明。
Endocrine. 2020 Apr;68(1):2-5. doi: 10.1007/s12020-020-02294-5.
10
Consensus statement from 2 International Conference on Controversies in Vitamin D.来自 2 次维生素 D 争议国际会议的共识声明。
Rev Endocr Metab Disord. 2020 Mar;21(1):89-116. doi: 10.1007/s11154-019-09532-w.
Zotero 插件